CAH CARDINAL HEALTH INC

NYSE cardinalhealth.com


$ 190.55 $ -0.55 (-0.29 %)    

Monday, 03-Nov-2025 18:49:43 EST
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 190.22
$ 191.65
$ 188.53 x 50
$ 190.70 x 49
$ 188.15 - $ 192.47
$ 109.06 - $ 197.67
2,503,802
na
45.2B
$ 0.63
$ 28.34
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-K
3 05-01-2025 03-31-2025 10-Q
4 01-30-2025 12-31-2024 10-Q
5 11-01-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-K
7 05-02-2024 03-31-2024 10-Q
8 02-01-2024 12-31-2023 10-Q
9 11-03-2023 09-30-2023 10-Q
10 08-15-2023 06-30-2023 10-K
11 05-04-2023 03-31-2023 10-Q
12 02-02-2023 12-31-2022 10-Q
13 11-04-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-K
15 05-05-2022 03-31-2022 10-Q
16 02-03-2022 12-31-2021 10-Q
17 11-09-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-K
19 05-06-2021 03-31-2021 10-Q
20 02-05-2021 12-31-2020 10-Q
21 11-05-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-K
23 05-11-2020 03-31-2020 10-Q
24 02-06-2020 12-31-2019 10-Q
25 11-07-2019 09-30-2019 10-Q
26 08-20-2019 06-30-2019 10-K
27 05-09-2019 03-31-2019 10-Q
28 02-07-2019 12-31-2018 10-Q
29 11-08-2018 09-30-2018 10-Q
30 08-22-2018 06-30-2018 10-K
31 05-09-2018 03-31-2018 10-Q
32 02-08-2018 12-31-2017 10-Q
33 11-07-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-K
35 05-02-2017 03-31-2017 10-Q
36 02-07-2017 12-31-2016 10-Q
37 11-02-2016 09-30-2016 10-Q
38 08-12-2016 06-30-2016 10-K
39 05-03-2016 03-31-2016 10-Q
40 02-02-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-cardinal-health-raises-price-target-to-225

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $183 to $225.

 citigroup-maintains-neutral-on-cardinal-health-raises-price-target-to-190

Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $16...

 ubs-maintains-buy-on-cardinal-health-raises-price-target-to-220

UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $185 to $220.

 evercore-isi-group-maintains-outperform-on-cardinal-health-raises-price-target-to-220

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price ta...

 marjorie-taylor-greene-buys-netflix-stock-after-downbeat-q3-earnings-expands-big-tech-bet

MTG "buys the dip" on Netflix (NFLX) stock after a bad Q3 report. See all 14 of her new purchases, including MSFT and A...

 meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

 cardinal-health-rallies-as-strong-start-to-2026-fuels-higher-earnings-guidance

Cardinal Health shares rise as Q1 earnings beat estimates, revenue jumps 22%, and the company lifts its 2026 earnings and cash ...

 cardinal-health-raises-fy2026-adj-eps-guidance-from-930-950-to-965-985-vs-943-est

Cardinal Health (NYSE:CAH) raises FY2026 Adj EPS guidance from $9.30-$9.50 to $9.65-$9.85 vs $9.43 analyst estimate..

 cardinal-health-q1-adj-eps-255-beats-218-estimate-sales-64009b-beat-59197b-estimate

Cardinal Health (NYSE:CAH) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.18 by...

 cardinal-health-plans-to-establish-distribution-center-in-indianapolis-indiana

DUBLIN, Ohio, Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distr...

Core News & Articles

https://www.youtube.com/watch?v=2KW1mVChh-c&feature=youtu.be

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION